China Regenerative Medicine International Limited (HKG:8158)
0.1800
-0.0180 (-9.09%)
Aug 28, 2026, 3:24 PM HKT
China Regenerative Medicine International Employees
China Regenerative Medicine International had 33 employees as of June 30, 2026.
Employees
33
Change
n/a
Growth
n/a
Revenue / Employee
2.62M HKD
Profits / Employee
834.52K HKD
Market Cap
54.77M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 33 | - | - | 33 | 0 |
| Dec 31, 2025 | 30 | -6 | -16.67% | 30 | 0 |
| Dec 31, 2024 | 36 | -10 | -21.74% | 34 | 2 |
| Dec 31, 2023 | 46 | 23 | 100.00% | 42 | 4 |
| Dec 31, 2022 | 23 | 2 | 9.52% | 20 | 3 |
| Jun 30, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Uni-Bio Science Group | 543 |
| Cutia Therapeutics | 304 |
| Immunotech Biopharm | 183 |
| 3D Medicines | 162 |
| Transcenta Holding | 155 |
| Kintor Pharmaceutical | 123 |
| Wuhan YZY Biopharma | 106 |
| Brii Biosciences | 75 |